Xencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last? [Yahoo! Finance]
Vulvar Cancer Pipeline Insight 2024, with Key Focus on TAK-242, Vudalimab, PEN-866, Artesunate, IRX-2, ISA101, VicOryx, PRV111, PRGN-2009, ABI-2280 and CUE-101 [Yahoo! Finance]
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at BTIG Research from $56.00 to $38.00. They now have a "buy" rating on the stock.
VIR-2218 + VIR- 3434 for Chronic Hepatitis B Drug Landscape Report 2024: 7MM Market Size, Forecast, and Emerging Insights 2019-2032 [Yahoo! Finance]